STING regulates peripheral nerve regeneration and colony stimulating factor 1 receptor (CSF1R) processing in microglia.

Saved in:
Bibliographic Details
Title: STING regulates peripheral nerve regeneration and colony stimulating factor 1 receptor (CSF1R) processing in microglia.
Authors: Morozzi G; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Rothen J; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Toussaint G; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., De Lange K; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Westritschnig K; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Doelemeyer A; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Ueberschlag VP; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Kahle P; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Lambert C; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Obrecht M; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Beckmann N; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Ritter V; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Panesar M; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Stauffer D; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Garnier I; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Mueller M; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Guerini D; Autoimmunity and Inflammation, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Keller CG; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Knehr J; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Roma G; Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Bidinosti M; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Brachat S; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Morvan F; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland., Fornaro M; Musculoskeletal Disease Area, Novartis Institutes for BioMedical Research, 4002 Basel, Switzerland.
Source: IScience [iScience] 2021 Nov 14; Vol. 24 (12), pp. 103434. Date of Electronic Publication: 2021 Nov 14 (Print Publication: 2021).
Publication Type: Journal Article
Journal Info: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2589-0042
DOI:10.1016/j.isci.2021.103434